An atypical case of neuroleptic malignant syndrome precipitated by valproate

BMJ Case Reports

Volumn , Issue , 2014, Pages

  Verma, Rajesh ^a   Junewar, Vivek ^a   Rathaur, Bhanu Pratap Singh ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; CREATINE KINASE; DOPAMINE RECEPTOR STIMULATING AGENT; ELECTROLYTE; ETIRACETAM; INFUSION FLUID; LORAZEPAM; OLANZAPINE; PRAMIPEXOLE; VALPROIC ACID;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENCEPHALITIS; FEMALE; FEVER; HUMAN; HYPONATREMIA; MIDDLE AGED; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PSYCHOSIS; SEIZURE; TACHYCARDIA; TACHYPNEA; VOMITING;

EID: 84898479140     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-202578     Document Type: Article

References (13)

1. Ananth J, Parameswaran S, Gunatilake S, et al. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry 2004;65:464-70.
2. Kashyap GL, Patel AG. Neuroleptic Malignant syndrome (NMS): a rare presentation induced by an antiemetic - case report. Psychiatr Danub 2011;23(Suppl 1):S43-5.
3. Ebadi M, Pfeiffer RF, Murrin LC. Pathogenesis and treatment of neuroleptic malignant syndrome. Gen Pharmacol 1990;21:367-86. (Pubitemid 20181448)
4. Järventausta K, Leinonen E. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment. Acta Psychiatr Scand 2000;102:231-3. (Pubitemid 30663333)
5. Patra BN, Khandelwal SK, Sood M. Olanzapine induced neuroleptic malignant syndrome. Indian J Pharmacol 2013;45:98-9.
6. Gortney JS, Fagan A, Kissack JC. Neuroleptic malignant syndrome secondary to quetiapine. Ann Pharmacother 2009;43:785-91.
7. Nisijima K, Kusakabe Y, Ohtuka K, et al. Addition of carbamazepine to long-term treatment with neuroleptics may induce neuroleptic malignant syndrome. Biol Psychiatry 1998;44:930-1.
8. Angelopoulos P, Markopoulou M, Kyamidis K, et al. Neuroleptic malignant syndrome without fever after addition of oxcarbazepine to long-term treatment with amisulpride. Gen Hosp Psychiatry 2008;30:482-4.
9. Ishioka M, Yasui-Furukori N, Hashimoto K, et al. Neuroleptic malignant syndrome induced by lamotrigine. Clin Neuropharmacol 2013;36:131-2.
10. Tadke RR, Suryavanshi P. Use of intravenous valproate in a patient with neuroleptic malignant syndrome. J Neuropsychiatry Clin Neurosci 2006;18:131-2. (Pubitemid 43277271)
11. Tanii H, Saka K, Inoue K, et al. Neuroleptic malignant syndrome following levomepromazine discontinuation. J Neuropsychiatry Clin Neurosci 2010;22:E16.
12. Ladds B, Thomas P, Mejia C, et al. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics. Am J Psychiatry 2009;166:114-15.
13. Erdoǧan S, Çelikel FC. Massive creatine kinase and hepatic enzyme elevation due to quetiapine and valproic acid treatment: a case report. Arch Neuropsychiatry 2012;49:238-40.